From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum.
Khatua K, Atla S, Coleman D, Blankenship LR, Alugubelli YR, Vulupala V, Guo XS, Xia H, Kalveram BK, Walker DH, Hurst BL, Kumar S, Cho CD, Sharma S, Yang K, Rabie D, Nyalata S, Neuman BW, Xie X, Xu S, Liu WR.
Khatua K, et al. Among authors: kumar s.
Nat Commun. 2026 Feb 14;17(1):2782. doi: 10.1038/s41467-026-69527-5.
Nat Commun. 2026.
PMID: 41690944
Free PMC article.